Eric C. McGary

1.4k total citations
22 papers, 1.1k citations indexed

About

Eric C. McGary is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eric C. McGary has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eric C. McGary's work include Chronic Myeloid Leukemia Treatments (4 papers), Melanoma and MAPK Pathways (3 papers) and Advanced Breast Cancer Therapies (2 papers). Eric C. McGary is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Melanoma and MAPK Pathways (3 papers) and Advanced Breast Cancer Therapies (2 papers). Eric C. McGary collaborates with scholars based in United States, Australia and United Kingdom. Eric C. McGary's co-authors include Menashe Bar‐Eli, Sui‐Yuan Chang, Dina Lev, S Chang, Maribelis Ruiz, Lisa Mills, Amy B. Heimberger, Janet E. Price, Barbara S. Beckman and Isaac J. Rondon and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Eric C. McGary

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric C. McGary United States 15 628 480 205 143 134 22 1.1k
Vanessa Baeriswyl Switzerland 12 728 1.2× 452 0.9× 190 0.9× 73 0.5× 150 1.1× 14 1.1k
Isao Matsuura United States 20 1.2k 1.9× 513 1.1× 127 0.6× 86 0.6× 164 1.2× 40 1.5k
Sheng-Bin Peng United States 20 954 1.5× 852 1.8× 196 1.0× 178 1.2× 358 2.7× 38 1.7k
Esra Gündüz Japan 21 858 1.4× 397 0.8× 240 1.2× 161 1.1× 105 0.8× 70 1.3k
H Hirai Japan 16 596 0.9× 332 0.7× 114 0.6× 56 0.4× 227 1.7× 36 1.1k
S Sakiyama Japan 21 874 1.4× 378 0.8× 237 1.2× 72 0.5× 148 1.1× 66 1.3k
Miguel Aracil Spain 20 679 1.1× 349 0.7× 268 1.3× 106 0.7× 199 1.5× 41 1.3k
Julia V. Burnier Canada 21 592 0.9× 408 0.8× 318 1.6× 123 0.9× 174 1.3× 73 1.2k
Barbara Frederick United States 19 889 1.4× 402 0.8× 395 1.9× 231 1.6× 101 0.8× 33 1.4k
Apollina Goel United States 18 639 1.0× 258 0.5× 110 0.5× 102 0.7× 138 1.0× 23 1.1k

Countries citing papers authored by Eric C. McGary

Since Specialization
Citations

This map shows the geographic impact of Eric C. McGary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. McGary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. McGary more than expected).

Fields of papers citing papers by Eric C. McGary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric C. McGary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. McGary. The network helps show where Eric C. McGary may publish in the future.

Co-authorship network of co-authors of Eric C. McGary

This figure shows the co-authorship network connecting the top 25 collaborators of Eric C. McGary. A scholar is included among the top collaborators of Eric C. McGary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric C. McGary. Eric C. McGary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Edelman, Martin J., Mary W. Redman, Kathy S. Albain, et al.. (2019). SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy). Journal of Thoracic Oncology. 14(10). 1853–1859. 51 indexed citations
3.
Morris, Michael J., Glenn Heller, Alan H. Bryce, et al.. (2019). Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 37(15_suppl). 5008–5008. 33 indexed citations
4.
McGary, Eric C., Kristy Weber, Lisa Mills, et al.. (2019). Editor's Note: Inhibition of Platelet-derived Growth Factor–mediated Proliferation of Osteosarcoma Cells by the Novel Tyrosine Kinase Inhibitor STI571. Clinical Cancer Research. 25(10). 3196–3196. 15 indexed citations
5.
Edelman, Martin J., Mary W. Redman, Kathy S. Albain, et al.. (2017). A phase II study of palbociclib (P) for previously treated cell cycle gene alteration positive patients (pts) with stage IV squamous cell lung cancer (SCC): Lung-MAP sub-study SWOG S1400C.. Journal of Clinical Oncology. 35(15_suppl). 9056–9056. 10 indexed citations
6.
Heimberger, Amy B., Eric C. McGary, Kenneth R. Hess, et al.. (2005). Mechanisms of action of rapamycin in gliomas. Neuro-Oncology. 7(1). 1–11. 29 indexed citations
7.
Heimberger, Amy B., Eric C. McGary, Dima Suki, et al.. (2005). Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.. PubMed. 11(1). 267–72. 65 indexed citations
8.
Heimberger, Amy B., Eric C. McGary, Dima Suki, et al.. (2005). Loss of the AP-2α Transcription Factor Is Associated with the Grade of Human Gliomas. Clinical Cancer Research. 11(1). 267–272. 37 indexed citations
9.
Lev, Dina, Amir Onn, Claudia P. Miller, et al.. (2004). Exposure of Melanoma Cells to Dacarbazine Results in Enhanced Tumor Growth and Metastasis In Vivo. Journal of Clinical Oncology. 22(11). 2092–2100. 108 indexed citations
10.
McGary, Eric C., Amir Onn, Lisa Mills, et al.. (2004). Imatinib Mesylate Inhibits Platelet-Derived Growth Factor Receptor Phosphorylation of Melanoma Cells But Does Not Affect Tumorigenicity In Vivo. Journal of Investigative Dermatology. 122(2). 400–405. 47 indexed citations
11.
Eton, Omar, Víctor G. Prieto, Darren W. Davis, et al.. (2004). Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM). Journal of Clinical Oncology. 22(14_suppl). 7528–7528. 32 indexed citations
12.
Messino, Michael J., Eric C. McGary, & Denise Williams. (2004). Epoetin Alfa 60,000 U SC QW Induction Followed by 60,000 U SC Q2W: Final Study Results of a Novel Treatment Strategy for Chemotherapy-Related Anemia.. Blood. 104(11). 4226–4226. 2 indexed citations
13.
Lev, Dina, Maribelis Ruiz, Lisa Mills, et al.. (2003). Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.. PubMed. 2(8). 753–63. 95 indexed citations
14.
McGary, Eric C., Dina Lev, & Menashe Bar‐Eli. (2002). Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma. Cancer Biology & Therapy. 1(5). 459–465. 119 indexed citations
15.
Ohigashi, Takashi, et al.. (1999). Protein kinase C α protein expression is necessary for sustained erythropoietin production in human hepatocellular carcinoma (Hep3B) cells exposed to hypoxia. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1450(2). 109–118. 12 indexed citations
16.
McGary, Eric C., Yan Tang, Aline B. Scandurro, et al.. (1999). Protein Kinase Cα Is an Effector of Hexamethylene Bisacetamide-Induced Differentiation of Friend Erythroleukemia Cells. Experimental Cell Research. 246(2). 348–354. 12 indexed citations
17.
McGary, Eric C., Isaac J. Rondon, & Barbara S. Beckman. (1997). Post-transcriptional Regulation of Erythropoietin mRNA Stability by Erythropoietin mRNA-binding Protein. Journal of Biological Chemistry. 272(13). 8628–8634. 70 indexed citations
18.
Unterman, Terry G., et al.. (1992). Cloning of the rat insulin-like growth factor binding protein-1 gene and analysis of its 5′ promoter region. Biochemical and Biophysical Research Communications. 185(3). 993–999. 25 indexed citations
19.
Smith, Cassandra L., et al.. (1989). Insertion of rare cutting sites nearby genes allows their rapid physical mapping: localization of theE.colimap locus. Nucleic Acids Research. 17(2). 817–817. 7 indexed citations
20.
Chang, Sui‐Yuan, Eric C. McGary, & S Chang. (1989). Methionine aminopeptidase gene of Escherichia coli is essential for cell growth. Journal of Bacteriology. 171(7). 4071–4072. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanessa Baeriswyl Breakdown of academic impact, for papers by Isao Matsuura Breakdown of academic impact, for papers by Sheng-Bin Peng Breakdown of academic impact, for papers by Esra Gündüz Breakdown of academic impact, for papers by H Hirai Breakdown of academic impact, for papers by S Sakiyama Breakdown of academic impact, for papers by Miguel Aracil Breakdown of academic impact, for papers by Julia V. Burnier Breakdown of academic impact, for papers by Barbara Frederick Breakdown of academic impact, for papers by Apollina Goel
Rankless by CCL
2026